Recombinant Mycobacterium marinum Elongation factor G (fusA), partial

What is Mycobacterium marinum and why is it used as a model organism for mycobacterial research?

Mycobacterium marinum is a pathogenic, slow-growing member of the genus Mycobacterium that causes fatal infections in salt- and freshwater fish as well as amphibians. In humans, it is the causative agent of swimming pool granuloma, a chronic skin infection of the extremities that can become systemic in immunocompromised patients such as those with AIDS . As a model organism, M. marinum offers several advantages: it shares high genetic similarity with M. tuberculosis, causes intracellular infections similar to tuberculosis, has a faster growth rate (7-14 days versus weeks to months for M. tuberculosis), and can be handled in BSL-2 facilities rather than the BSL-3 required for M. tuberculosis . Experimental infection with M. marinum in fish mimics tuberculosis pathogenesis, making it valuable for studying mycobacterial pathogenicity mechanisms .

What is the structure and function of Elongation factor G (fusA) in mycobacteria?

Elongation factor G (EF-G), encoded by the fusA gene, is a critical GTPase that catalyzes the translocation step during protein synthesis on the ribosome. The protein typically has five domains and functions to:

• Promote translocation of peptidyl-tRNA from the A-site to the P-site on the ribosome

• Facilitate the movement of mRNA by one codon

• Catalyze the release of deacylated tRNA from the E-site

• Contribute to ribosomal recycling after termination

The fusA protein is essential for bacterial survival, making it a potential antibiotic target. Some antimicrobials, such as fusidic acid, specifically inhibit EF-G by preventing its release from the ribosome after GTP hydrolysis . The structure of mycobacterial fusA is highly conserved across the genus, reflecting its essential function in protein synthesis.

How conserved is the fusA gene across mycobacterial species?

The fusA gene exhibits high conservation across mycobacterial species due to its essential role in protein synthesis. When comparing M. marinum fusA with other mycobacterial species:

This high sequence conservation facilitates comparative studies and allows insights gained from M. marinum fusA research to be applied to pathogenic species like M. tuberculosis . Multilocus sequence analysis has been applied to mycobacterial species, although genotyping of M. marinum does not clearly relate to geographic origins of isolates, unlike for M. ulcerans .

What are optimal growth conditions for M. marinum cultures when expressing recombinant fusA?

Optimal growth conditions for M. marinum differ significantly from those of other mycobacteria and must be carefully controlled for successful recombinant fusA expression:

• Temperature: M. marinum grows optimally at 30°C, not 37°C like M. tuberculosis . Growth at temperatures above 33°C can stress the organism and reduce recombinant protein yield.

• Media: Use Middlebrook 7H9 broth supplemented with:

  • ADC or OADC (albumin, dextrose, catalase with or without oleic acid)

  • 0.05% Tween 80 to prevent clumping

  • Appropriate antibiotics for plasmid maintenance

• Growth phase: Late exponential phase (5-7 days) typically yields optimal protein expression.

• Special considerations:

  • Growth in the dark is recommended if using photochromogenic strains, as M. marinum exhibits photochromogenicity with colonies turning yellow upon exposure to light

  • Avoid excessive aeration, which can lead to oxidative stress

  • For microscopy, M. marinum grows with photochromogenic colonies that can be difficult to differentiate from M. ulcerans on a molecular basis

It's essential to note that primary cultivation of M. marinum requires low temperature (30°C) and several weeks to succeed, making it sometimes difficult to isolate in clinical microbiology settings .

What transformation methods are most effective for M. marinum?

• Electroporation:

  • Prepare competent cells by washing in 10% glycerol

  • Use 1-5 μg of high-quality plasmid DNA

  • Electroporate at 2.5 kV, 25 μF, 1000 Ω

  • Immediately recover in 7H9-ADC-Tween medium at 30°C

  • Incubate plates at 30°C for 7-14 days

• Phage-based methods:

  • Conditionally replicating mycobacteriophages like phAE94 (originally developed for M. tuberculosis) can be adapted for M. marinum

  • These phages facilitate highly efficient transposon delivery in M. marinum

  • Using this technique, researchers have successfully generated representative mutant libraries of M. marinum

  • Southern hybridization and PCR analysis with primers distributed over the TM4 genome can be used to detect residual phAE94 sequences in the M. marinum mutants

The phage-based approach is particularly valuable because conditions permissive for phage replication in M. tuberculosis facilitate highly efficient transposon delivery in M. marinum, circumventing the traditionally low transformation efficiencies for this species .

What are effective strategies for expressing and purifying recombinant fusA from M. marinum?

Successful expression and purification of recombinant fusA from M. marinum requires consideration of several factors:

• Expression system selection:

  • Mycobacterial shuttle vectors (e.g., pMyong2, pMV261) that replicate in both E. coli and mycobacteria

  • Promoter selection: constitutive (hsp60) for continuous expression or inducible (acetamidase) for controlled expression

  • Fusion tags: His6 tags for purification, with TEV protease cleavage sites for tag removal

• Expression optimization:

  • Expression at 30°C (optimal for M. marinum)

  • Induction at mid-logarithmic phase for inducible systems

  • Harvest cells in late exponential phase

• Cell lysis strategies:

  • Combination of enzymatic (lysozyme) and mechanical (sonication, bead beating) lysis

  • Include protease inhibitors to prevent degradation

  • Clarify lysate by high-speed centrifugation

• Purification approach:

  • Immobilized metal affinity chromatography (IMAC) for His-tagged proteins

  • Ion exchange chromatography as a secondary purification step

  • Size exclusion chromatography for final polishing

  • Include stabilizing agents: glycerol (10%), reducing agents (DTT or β-mercaptoethanol), and MgCl₂ (5 mM)

For particularly challenging preparations, utilizing M. smegmatis as an alternative host for expressing M. marinum fusA can provide a faster growth rate while maintaining a mycobacterial expression environment.

How can recombinant M. marinum fusA be used to study antibiotic resistance mechanisms?

Recombinant M. marinum fusA provides a valuable tool for studying antibiotic resistance mechanisms, particularly for translation-targeting antibiotics:

• Fusidic acid resistance studies:

  • Fusidic acid targets EF-G by binding to the protein and preventing its release from the ribosome after GTP hydrolysis

  • Site-directed mutagenesis of recombinant fusA can generate known resistance mutations

  • These mutants can be characterized biochemically to understand structural mechanisms of resistance

• Cross-resistance evaluation:

  • Expressing fusA variants in model systems to determine effects on susceptibility to various antibiotics

  • Establishing whether fusA mutations confer resistance to multiple translation inhibitors

• Structure-based drug design:

  • Using purified recombinant fusA for co-crystallization with antibiotics

  • Identifying novel binding sites for developing new antimycobacterial agents

• In vivo validation through:

  • Complementation studies in fusA-depleted strains

  • Determination of minimal inhibitory concentrations (MICs) for various antibiotics

  • Assessment of fitness costs associated with resistance mutations

This research is particularly valuable as M. marinum is less susceptible to antimicrobial agents than other non-tuberculous mycobacteria, requiring longer treatment regimens . Standard treatment for M. marinum infection has not been firmly established, though a combination of antimicrobial agents such as cyclines and rifampin has shown success in skin infections .

How can transposon mutagenesis be applied to study fusA function in M. marinum?

Transposon mutagenesis provides a powerful approach for studying fusA function in M. marinum:

• Library generation:

  • The conditionally replicating mycobacteriophage phAE94 can be used to deliver the transposon Tn5367 into M. marinum

  • This approach has successfully generated representative mutant libraries in M. marinum

  • BLAST analysis of the sequences adjacent to transposon insertion sites can reveal high homology to M. marinum and M. tuberculosis genes

• Screening strategies:

  • Selecting for fusidic acid resistance to identify fusA mutants

  • Using conditional expression systems to complement essential gene function

  • Screening for growth defects under various stress conditions

• Characterization of insertion sites:

  • Sequencing transposon junctions using primers like RPCRa2 and RPCRb2

  • Analysis shows that insertions are typically flanked by a unique 8-bp target duplication, as previously described for transposition of Tn5367 in other mycobacterial strains

  • Southern hybridization and PCR can confirm the absence of residual phage sequences

• Functional validation:

  • Complementation with wild-type fusA to confirm phenotypes

  • Biochemical characterization of mutant fusA proteins

  • In vivo growth and virulence assessment

This approach is particularly valuable since Tn5367 appears to transpose with no sequence specificity into the genome of M. marinum , allowing comprehensive mutagenesis across the chromosome.

What in vivo models are suitable for studying M. marinum fusA function in pathogenesis?

Several in vivo models are suitable for studying M. marinum pathogenesis and the role of fusA:

• Fish models:

  • Zebrafish (Danio rerio) embryos and adults provide a natural host model

  • Transparent embryos allow real-time visualization of infection

  • Genetic manipulation of both host and pathogen is possible

• Mouse footpad infection model:

  • Cutaneous infection in mouse footpads mimics human granulomatous disease

  • Novel imaging techniques have been developed to assess antimicrobial efficacy

  • This model demonstrates that combining clarithromycin, rifampicin, ethambutol, and minocycline effectively clears M. marinum from infected footpads

  • Granulomas with necrotic abscesses form primarily due to neutrophil involvement in the host's cell-mediated immune response

• Cell culture systems:

  • Macrophage infection models (murine or human)

  • Ability to study intracellular survival and replication

  • Assessment of fusA role in stress response within host cells

• Imaging applications:

  • Fluorescent protein or luciferase reporters can be used to visualize bacteria

  • Non-invasive in vivo imaging methods have been developed to assess therapeutic efficacy against M. marinum infection

  • These techniques provide valuable insights into bacterial visualization across various bacterial infections

These models are particularly valuable because immune mediators and cells induced by M. marinum footpad infection mirror key factors associated with hypersensitivity and granuloma formation seen in pulmonary tuberculosis .

What analytical methods can be used to study structure-function relationships in M. marinum fusA?

Multiple complementary analytical methods can elucidate structure-function relationships in M. marinum fusA:

• Structural biology approaches:

  • X-ray crystallography of purified recombinant fusA

  • Cryo-electron microscopy for visualizing fusA-ribosome complexes

  • NMR spectroscopy for analyzing protein dynamics

  • Small-angle X-ray scattering (SAXS) for solution structure determination

• Functional domain mapping:

  • Site-directed mutagenesis of conserved residues

  • Construction of chimeric proteins with domains from other species

  • Truncation analysis to identify minimal functional units

• Biochemical characterization:

  • GTPase activity assays (measuring phosphate release)

  • Ribosome binding assays (filter binding or fluorescence anisotropy)

  • Translocation assays using fluorescently labeled tRNAs

  • Thermal shift assays to assess protein stability

• Computational approaches:

  • Homology modeling based on known EF-G structures

  • Molecular dynamics simulations to study conformational changes

  • Sequence analysis and conservation mapping

These methods can reveal how specific domains contribute to fusA function and how mutations might affect antibiotic susceptibility or protein synthesis efficiency in mycobacteria.

What controls are essential when performing experiments with recombinant M. marinum fusA?

Rigorous controls are essential when working with recombinant M. marinum fusA to ensure reliable and interpretable results:

• Protein quality controls:

  • Purity assessment via SDS-PAGE and Western blotting

  • Activity verification using GTPase assays

  • Thermal stability analysis to confirm proper folding

  • Mass spectrometry to confirm protein identity and detect modifications

• Enzymatic activity controls:

  • No-enzyme control (reaction mixture without fusA)

  • Heat-inactivated enzyme control (fusA boiled for 10 minutes)

  • Positive control (commercial GTPase with known activity)

  • Substrate specificity control (testing activity with ATP vs. GTP)

• Tag effect controls:

  • Comparison of tagged versus untagged protein

  • Tag-cleaved protein to confirm activity independent of tag

  • Multiple tag positions (N-terminal vs. C-terminal) to identify interference

• Ribosome interaction controls:

  • Ribosomes from relevant species (mycobacterial preferred)

  • Ribosome activity verification with standard translation assays

  • Competition with excess unlabeled fusA to demonstrate specificity

• Experimental reproducibility controls:

  • Technical replicates (same preparation, multiple measurements)

  • Biological replicates (independent preparations)

  • Inter-laboratory validation when possible

How should kinetic data from recombinant fusA experiments be analyzed?

Analyzing kinetic data from recombinant fusA experiments requires systematic approaches to extract meaningful parameters:

• Steady-state kinetics analysis:

  • Determine initial rates at multiple substrate concentrations

  • Fit data to Michaelis-Menten equation: v = Vmax × [S] / (Km + [S])

  • Extract key parameters: Km (substrate affinity), kcat (catalytic rate), and kcat/Km (catalytic efficiency)

  • Create Lineweaver-Burk or Eadie-Hofstee plots for visualization and linearity checks

• Ribosome-stimulated GTPase analysis:

  • Compare basal and ribosome-stimulated activities

  • Determine stimulation factor (fold increase in activity)

  • Calculate EC50 for ribosome concentration giving half-maximal stimulation

  • Assess changes in Km and kcat values with ribosome addition

• Inhibition studies:

  • Determine inhibition type (competitive, noncompetitive, uncompetitive)

  • Calculate Ki (inhibition constant) using appropriate equations

  • For time-dependent inhibitors like fusidic acid, analyze pre-steady-state and steady-state phases separately

• Data fitting and statistical analysis:

  • Use non-linear regression for parameter estimation

  • Calculate confidence intervals for all parameters

  • Apply appropriate statistical tests for comparing conditions

  • Consider global fitting for complex mechanisms

Expected parameter ranges for functional M. marinum fusA include:

• Km for GTP: 10-100 μM

• kcat: 0.1-5 min⁻¹ (unstimulated) and 1-50 min⁻¹ (ribosome-stimulated)

• Ribosome binding affinity: 0.1-1 μM

Deviations from these ranges may indicate alterations in protein function due to mutations, experimental conditions, or protein quality issues.

What are common issues in purifying functional recombinant fusA from M. marinum?

Purifying functional recombinant fusA from M. marinum presents several challenges that require specific troubleshooting strategies:

• Protein solubility issues:

  • Problem: Recombinant fusA tends to form inclusion bodies or aggregate

  • Solutions:

    • Express at lower temperature (25°C)

    • Add solubility enhancers (5-10% glycerol, 1 mM DTT)

    • Include mild detergents (0.05% Tween-20)

    • Consider fusion partners (SUMO, MBP) that enhance solubility

• Protein degradation:

  • Problem: Proteolytic degradation during purification

  • Solutions:

    • Work quickly and keep samples cold (4°C)

    • Include protease inhibitor cocktail in all buffers

    • Add EDTA (1 mM) to chelate metal ions that activate proteases

    • Consider engineering constructs without sensitive protease sites

• Low yield:

  • Problem: Poor expression or recovery of recombinant fusA

  • Solutions:

    • Optimize codon usage for expression host

    • Test different promoters and induction conditions

    • Improve cell lysis (combination of enzymatic and mechanical methods)

    • Optimize purification protocol to minimize losses

• Loss of activity:

  • Problem: Purified protein shows low GTPase activity

  • Solutions:

    • Include GTP or non-hydrolyzable analog during purification

    • Add magnesium (5 mM MgCl₂) to stabilize nucleotide binding

    • Use reducing agents to maintain cysteine residues

    • Avoid freeze-thaw cycles by preparing small aliquots

• Contaminating proteins:

  • Problem: Co-purifying proteins reduce purity

  • Solutions:

    • Use more stringent washing conditions during affinity chromatography

    • Add secondary purification steps (ion exchange, size exclusion)

    • Consider on-column refolding for difficult preparations

    • Verify protein identity by mass spectrometry

These troubleshooting strategies increase the likelihood of obtaining functional recombinant fusA suitable for downstream structural and functional studies.

How can researchers overcome challenges in developing M. marinum genetic tools for fusA studies?

Researchers face several challenges when developing genetic tools for fusA studies in M. marinum, but multiple strategies can overcome these limitations:

• Low transformation efficiency:

  • Challenge: Traditional electroporation yields low efficiency

  • Solutions:

    • Use optimized competent cell preparation (fresh cells, multiple glycerol washes)

    • Employ phage-based delivery systems like phAE94, which has been successfully adapted to M. marinum

    • Conditions permissive for phage replication in M. tuberculosis facilitate highly efficient transposon delivery in M. marinum

    • Consider specialized electroporation conditions (pulse settings, buffer composition)

• Essential gene manipulation:

  • Challenge: fusA is essential, making knockout studies difficult

  • Solutions:

    • Create conditional knockdown systems (tetracycline-responsive)

    • Use CRISPR interference (CRISPRi) for partial repression

    • Employ complementation strategies with recombinant wild-type before manipulation

    • Create merodiploid strains with a second copy of fusA before inactivating the native gene

• Genetic stability issues:

  • Challenge: Plasmids can be unstable in mycobacteria

  • Solutions:

    • Use integrative vectors for stable maintenance

    • Include appropriate antibiotic selection throughout growth

    • Verify genotype stability through PCR or sequencing

    • Monitor for suppressor mutations that might arise

• Specificity of genetic modifications:

  • Challenge: Ensuring precise modifications without off-target effects

  • Solutions:

    • Sequence verification of constructs and modified strains

    • Southern blot analysis to confirm single integration events

    • Complementation studies to confirm phenotype specificity

    • BLAST analysis of insertion junctions to verify specificity

• Phenotypic analysis:

  • Challenge: Connecting genetic changes to phenotypes

  • Solutions:

    • Develop appropriate functional assays (growth, antibiotic susceptibility)

    • Use reporter systems (GFP, luciferase) for tracking expression

    • Implement in vivo imaging techniques for assessing antimicrobial efficacy

    • Combine genetic, biochemical, and structural approaches for comprehensive analysis

By implementing these strategies, researchers can overcome the technical challenges associated with genetic manipulation of fusA in M. marinum.

What approaches are most effective for maintaining stability of purified recombinant fusA?

Maintaining stability of purified recombinant fusA requires careful attention to storage conditions and buffer composition:

• Buffer optimization:

  • Base buffer: 20-50 mM Tris-HCl or HEPES pH 7.5

  • Salt: 100-200 mM NaCl or KCl for ionic strength

  • Additives:

    • 5-10% glycerol to prevent freezing damage and aggregation

    • 1-5 mM MgCl₂ to stabilize nucleotide binding

    • 1-2 mM DTT or TCEP as reducing agents (add fresh)

    • 0.1-0.5 mM GTP or non-hydrolyzable analog

• Short-term storage (up to 1 week):

  • Store at 4°C in optimized buffer

  • Filter sterilize (0.22 μm) to prevent microbial growth

  • Add sodium azide (0.02%) as preservative if not interfering with downstream applications

  • Monitor activity periodically with simple GTPase assays

• Long-term storage:

  • Prepare small aliquots (50-100 μL) to avoid freeze-thaw cycles

  • Flash freeze in liquid nitrogen before transferring to -80°C

  • Increase glycerol concentration to 15-20% for cryoprotection

  • Consider lyophilization with appropriate lyoprotectants (sucrose, trehalose)

• Stability monitoring:

  • Activity assays to track functional stability over time

  • SDS-PAGE analysis to detect degradation

  • Dynamic light scattering to monitor aggregation

  • Thermal shift assays to assess conformational stability

Implementing these practices helps maintain protein activity and integrity for extended periods, ensuring reliable results in downstream applications.